AASLD 2016: Hepatocellular Carcinoma (Liver Cancer) Abstract’s # 57, # 1768, #162 | Lucinda K. Porter, RN
Abstract #57 Poor Adherence to Hepatocellar Carcinoma (HCC) Surveillance in a U.S. Cohort of 2376 Patients with Chronic Hepatitis C (CHC) and Cirrhosis-Sally A. Tran, et al.
Abstract #1768 Identifying Barriers to Hepatocellular Carcinoma Surveillance in a National Sample of patients with Cirrhosis-David S. Goldberg, et al.
Abstract # 1762 Lack of Compliance to Hepatocellular Carcinoma (HCC) Screening Guidelines in Hepatitis B (HBV) or C (HCV) Virus Co-Infected HIV Patients with Cirrhosis-Sophie Willemse (Netherlands)
The incidence of liver cancer is rising. Several studies looked at how effective the medical profession is doing at screening for hepatocellular carcinoma (HCC).
Conclusion: These three large studies (two in the U.S. and one in the Netherlands) concluded that surveillance is poor.
Editorial Comments: If you have cirrhosis or hepatitis B (with/without cirrhosis), talk to your doctor about HCC screening recommendations. In the U.S., screening includes imaging (ultrasound, CT, or MRI) every 6 months.Share!